Keys for Meaningful Anticoagulation

Posted on: November 12, 2025

Explore Assays from DiaPharma to Enhance Your Anticoagulation Research

FXIa Research Assays from DiaPharma

DAPTTIN® TC Reagent*

  • Sensitive reagent for detecting FXIa inhibition in plasma
  • Double activated aPTT reagent with sulfatides and silica as surface activators, plus an optimal mixture of highly purified phospholipids

Thrombin Generation Assays*

  • Evaluate FXIa inhibitor pharmacodynamics
  • Manual and automated options

Chromogenic Substrates and Reagents*

  • Chromogenic substrates sensitive to FXIa, FXIIa, FXa, and FIIa (Thrombin)
  • S-2366 enables direct measurement of FXIa activity, relevant for contact pathway activation studies

DOAC-STOP™ Tablets*

  • The original DOAC eliminator
  • Effectively eliminate interference from DOACs and FXIa inhibitors in plasma to get accurate research results
  • NEW! Now available: DOAC-Stop™ L* (liquid form) and DOAC-Stop™ µ* (for small sample sizes). Contact us for samples
  • NEW! Antihepca™-HRRS*
    • Heparin Resistant Recalcifying Solution
    • Simple and quick recalcifying reagent to neutralize heparin contamination
Find Your Territory Manager

* For research use only. Not for use in diagnostic procedures.

ML-00-01251 Rev 01